Chabot S, Williams G, Yong V W
Neuroimmunology Unit, Department of Neurology and Neurosurgery, McGill University, Montreal Neurological Institute, Montreal, Quebec, Canada H3A 2B4.
J Clin Invest. 1997 Aug 1;100(3):604-12. doi: 10.1172/JCI119571.
TNF-alpha is a proinflammatory cytokine involved in many inflammatory conditions such as Crohn's disease, rheumatoid arthritis, cachexia, AIDS, and multiple sclerosis (MS). TNF-alpha is produced mainly by cells of the macrophage lineage, which includes microglia in the central nervous system. Here, we describe a mechanism through which TNF-alpha is generated by microglia. We show that activated human T lymphocytes induce the microglial production of TNF-alpha, and that is attenuated by a functional blocking antibody to CD49d, the alpha chain of the VLA-4 integrin on T cells. We also report that interferonbeta-1b (IFNbeta-1b), a drug that alleviates symptoms in MS, downregulates the expression of CD49d and reduces TNF-alpha production, mechanisms which can help account for its efficacy in MS.
肿瘤坏死因子-α(TNF-α)是一种促炎细胞因子,参与多种炎症性疾病,如克罗恩病、类风湿性关节炎、恶病质、艾滋病和多发性硬化症(MS)。TNF-α主要由巨噬细胞谱系的细胞产生,其中包括中枢神经系统中的小胶质细胞。在此,我们描述了一种小胶质细胞产生TNF-α的机制。我们发现活化的人T淋巴细胞可诱导小胶质细胞产生TNF-α,而针对T细胞上VLA-4整合素α链CD49d的功能性阻断抗体可减弱这种诱导作用。我们还报告称,干扰素β-1b(IFNβ-1b),一种可缓解MS症状的药物,可下调CD49d的表达并减少TNF-α的产生,这些机制有助于解释其在MS中的疗效。